Rapid response to Dasatinib in a CML blast crisis patient that subsequently developed sequential Bcr-Abl mutations causing multi-drug resistance: A case report

被引：0
|
作者：
Stagno, F. [1 ]
Stella, S. [1 ]
Berretta, S. [1 ]
Massimino, M. [1 ]
Antolino, A. [1 ]
Vigneri, P. [1 ]
Di Raimondo, F. [1 ]
机构：
[1] Univ Catania, Dept Biomed Sci, Hematol & Pathol Sect, Catania, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：181 / 181
页数：1
相关论文
共 9 条
  • [1] BCR-ABL Mutation-Guided Therapy for CML Blast Crisis: A Case Report
    Ostendorf, Benjamin N.
    Nogai, Hendrik
    Baldus, Claudia D.
    Burmeister, Thomas
    Arnold, Renate
    BIOMARKER INSIGHTS, 2015, 10 : 25 - 28
  • [2] Imatinib failure and response to dasatinib in a patient with chronic myeloid leukemia in blast crisis and a novel, nine-nucleotide BCR-ABL insertion mutation
    Sigl, M.
    Spoerl, S.
    Schnittger, S.
    Meissner, J.
    Rummelt, C.
    Peschel, C.
    Duyster, J.
    Ho, A. D.
    von Bubnoff, N.
    BLOOD CANCER JOURNAL, 2013, 3 : e104 - e104
  • [3] Imatinib failure and response to dasatinib in a patient with chronic myeloid leukemia in blast crisis and a novel, nine-nucleotide BCR-ABL insertion mutation
    M Sigl
    S Spoerl
    S Schnittger
    J Meissner
    C Rummelt
    C Peschel
    J Duyster
    A D Ho
    N von Bubnoff
    Blood Cancer Journal, 2013, 3 : e104 - e104
  • [4] Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis
    Stagno, Fabio
    Stella, Stefania
    Berretta, Salvatore
    Massimino, Michele
    Antolino, Agostino
    Giustolisi, Rosario
    Messina, Angelo
    Di Raimondo, Francesco
    Vigneri, Paolo
    LEUKEMIA RESEARCH, 2008, 32 (04) : 673 - 674
  • [5] A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance: sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
    Sakai, Katsuya
    Ishikawa, Yuichi
    Mori, Yumiko
    Kobayashi, Miki
    Iriyama, Chisako
    Ozawa, Yukiyasu
    Suzuki, Tatsuya
    Minami, Yosuke
    Ishikawa, Kazuhiro
    Kaneda, Norio
    Naoe, Tomoki
    Kiyoi, Hitoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (02) : 237 - 242
  • [6] Detection of Low Level Nilotinib or Dasatinib Resistant BCR-ABL Mutations by Mass Spectrometry In CML Patients Who Fail Imatinib Is Highly Predictive of Their Subsequent Clonal Expansion When Treated with the Drug for Which Their Mutation Confers Resistance
    Parker, Wendy T.
    Hoi, Musei
    Lawrence, Rebecca M.
    Irwin, Darryl L.
    Scott, Hamish S.
    Hughes, Timothy
    Branford, Susan
    BLOOD, 2010, 116 (21) : 390 - 391
  • [7] A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance: sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
    Katsuya Sakai
    Yuichi Ishikawa
    Yumiko Mori
    Miki Kobayashi
    Chisako Iriyama
    Yukiyasu Ozawa
    Tatsuya Suzuki
    Yosuke Minami
    Kazuhiro Ishikawa
    Norio Kaneda
    Tomoki Naoe
    Hitoshi Kiyoi
    International Journal of Hematology, 2011, 93 : 237 - 242
  • [8] Biclonal blast crisis with a mutated ABL catalytic domain in a Ph, del (9q)-positive CML patient responsive to imatinib: drug resistance should be monitored in all patients irrespective of response status
    Alimena, G
    Breccia, M
    Mancini, M
    Diverio, D
    Nanni, M
    De Propris, MS
    Cimino, G
    Pane, F
    Mandelli, F
    LEUKEMIA, 2005, 19 (02) : 287 - 289
  • [9] Biclonal blast crisis with a mutated ABL catalytic domain in a Ph, del (9q)-positive CML patient responsive to imatinib: drug resistance should be monitored in all patients irrespective of response status
    G Alimena
    M Breccia
    M Mancini
    D Diverio
    M Nanni
    M S De Propris
    G Cimino
    F Pane
    F Mandelli
    Leukemia, 2005, 19 : 287 - 289
1